Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Neurocrine Biosciences (NBIX) Accumulated Expenses: 2010-2019

Historic Accumulated Expenses for Neurocrine Biosciences (NBIX) over the last 10 years, with Dec 2019 value amounting to $38.9 million.

  • Neurocrine Biosciences' Accumulated Expenses rose 42.43% to $38.9 million in Q4 2019 from the same period last year, while for Dec 2019 it was $38.9 million, marking a year-over-year increase of 42.43%. This contributed to the annual value of $38.9 million for FY2019, which is 42.43% up from last year.
  • Neurocrine Biosciences' Accumulated Expenses amounted to $38.9 million in FY2019, which was up 42.43% from $27.3 million recorded in FY2018.
  • Neurocrine Biosciences' Accumulated Expenses' 5-year high stood at $38.9 million during FY2019, with a 5-year trough of $9.6 million in FY2016.
  • In the last 3 years, Neurocrine Biosciences' Accumulated Expenses had a median value of $27.3 million in 2018 and averaged $30.4 million.
  • As far as peak fluctuations go, Neurocrine Biosciences' Accumulated Expenses slumped by 49.78% in 2016, and later soared by 160.50% in 2017.
  • Over the past 5 years, Neurocrine Biosciences' Accumulated Expenses (Yearly) stood at $19.0 million in 2015, then slumped by 49.78% to $9.6 million in 2016, then spiked by 160.50% to $24.9 million in 2017, then increased by 9.80% to $27.3 million in 2018, then soared by 42.43% to $38.9 million in 2019.